-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

BMO Capital Adjusts Price Target on Pacira BioSciences to $52 From $60, Maintains Market Perform Rating

BMO Capital Adjusts Price Target on Pacira BioSciences to $52 From $60, Maintains Market Perform Rating

MT Newswires · 01/06/2023 03:54